A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer
Clinical trial NCT00298688 · COMPLETED
Trial details
- NCT number
- NCT00298688
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.